Skip to content

Ping An Biomedical Co., Ltd.

PASW

CIK 0001897532

← back to feed
Revenue (TTM)
¥4.8M
−94.5% YoY FY Sep 2025
Net Income (TTM)
−¥1.8M
−40.3% YoY FY Sep 2025
EPS Diluted (TTM)
−¥0.10
−42.9% YoY FY Sep 2025
Gross Margin
2.8%
FY Sep 2025
Operating Margin
-43.1%
FY Sep 2025
Net Margin
-37.6%
FY Sep 2025
Free Cash Flow (TTM)
—
FY Sep 2025
Cash
¥164.7K
FY Sep 2025
Total Debt
¥1.4M
FY Sep 2025
Shares Outstanding
20.5M sh
FY Sep 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings